Cart
sales@molnova.com
(Z)-PUGNAc
CAS No. 132489-69-1
(Z)-PUGNAc( —— )
Catalog No. M35061 CAS No. 132489-69-1
(Z)-PUGNAc, a potent O-GlcNAcase inhibitor more active than (E)-PUGNAc, removes O-GlcNAc from proteins (peptide O-GlcNAc-β-N-acetylaminoglucosidase) and can be used to increase levels of O-GlcNAc on nuclear and cytoplasmic proteins in vivo.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 150 | In Stock |
|
| 10MG | 278 | In Stock |
|
| 25MG | 472 | In Stock |
|
| 50MG | 675 | In Stock |
|
| 100MG | 911 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name(Z)-PUGNAc
-
NoteResearch use only, not for human use.
-
Brief Description(Z)-PUGNAc, a potent O-GlcNAcase inhibitor more active than (E)-PUGNAc, removes O-GlcNAc from proteins (peptide O-GlcNAc-β-N-acetylaminoglucosidase) and can be used to increase levels of O-GlcNAc on nuclear and cytoplasmic proteins in vivo.
-
Description(Z)-PUGNAc is a potent O-GlcNAcase inhibitor. (Z)-PUGNAc is a vastly more potent inhibitor of O-GlcNAcase than the E form.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number132489-69-1
-
Formula Weight353.33
-
Molecular FormulaC15H19N3O7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (141.51 mM; Ultrasonic )
-
SMILESCC(=O)NC1C(O)C(O)C(CO)OC1=NOC(=O)Nc1ccccc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Perreira M, et al. Inhibition of O-GlcNAcase by PUGNAc is dependent upon the oxime stereochemistry. Bioorg Med Chem. 2006;14(3):837-846. ?
molnova catalog
related products
-
Gitogenin
Gitogenin, tigogenin, and solasodine are novel selective inhibitors of UGT1A4, and do not inhibit the activities of major human CYP isoforms.
-
Fibrinogen Related P...
Fibrinogen γ-chain (397-411), a esidues 397-411 of the γ chain of fibrinogen, is a site recognizing the platelet receptor, which is distinct from the site(s) involved in polymerization of fibrin monomers.
-
MCI-225
MCI-225 is a selective inhibitor of NA reuptake with 5-HT3 receptor antagonism.MCI-225 (10 mg/kg, po) showed comparable anxiolytic-like effect between single and 5-day repeated administration.?
